Rilpivirine
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1671 publications
Letter to the editor: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: January 16, 2026
Authors' response: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: January 16, 2026
Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and Selectivity.
Journal: Journal of medicinal chemistry
Published: January 09, 2026
Evaluating long-acting injectable HIV treatment: an update on cabotegravir and rilpivirine.
Journal: Expert review of anti-infective therapy
Published: January 08, 2026
Subscription-Based Pricing for Lenacapavir-Learning From Hepatitis C and Cabotegravir.
Journal: JAMA
Published: January 07, 2026
Cabotegravir injectable PrEP approved in England and Wales.
Journal: The lancet. HIV
Published: December 07, 2025
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years.
Journal: Open forum infectious diseases
Published: December 06, 2025
Preexposure Prophylaxis Prescription Dispensation Status and HIV-1 Acquisition.
Journal: JAMA network open
Published: December 04, 2025
To err is human, to persist is diabolical: Are we repeating the same cost and insurance coverage mistakes again with injectable PrEP?
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 02, 2025
Canadian guideline on HIV pre- and postexposure prophylaxis: 2025 update.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: December 01, 2025
Impact of Gluteal Injection Site on Pharmacokinetics and Tolerability of Antiretroviral Therapy with Long-Acting Cabotegravir and Rilpivirine.
Journal: AIDS patient care and STDs
Published: November 17, 2025
Last Updated: 02/24/2026